Lebenthal Asset Management’s Pfizer PFE Stock Holding History

Lebenthal Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$5.92M	Buy	182,554 +8,880	+5%	+$280K	0.73%	33
2016 Q4	$5.35M	Buy	173,674 +820	+0.5%	+$25K	0.69%	40
2016 Q3	$5.55M	Sell	172,854 -5,567	-3%	-$186K	0.72%	32
2016 Q2	$5.96M	Buy	178,421 +160,788	+912%	+$5.13M	0.77%	29
2016 Q1	$496K	Buy	+17,633	New	+$504K	0.2%	67

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Lebenthal Asset Management's PFE Position: Q1 2017 in Review

Lebenthal Asset Management increased its Pfizer (PFE) stake by 5.1% in Q1 2017, buying an estimated $280K and bringing the position to 182,554 shares worth $5.92M. The position accounts for 0.73% of the portfolio, ranked #33.

Lebenthal Asset Management first reported a position in PFE in Q1 2016 and has held it in 5 quarters since. The position peaked at $5.96M in Q2 2016. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

Lebenthal Asset Management held 182,554 shares of Pfizer worth $5.92M as of Q1 2017.
Lebenthal Asset Management bought 8,880 Pfizer shares in Q1 2017, an estimated $280K.
Pfizer made up 0.73% of Lebenthal Asset Management's portfolio in Q1 2017, its #33 holding.
Lebenthal Asset Management first reported a position in Pfizer in Q1 2016 and has held it in 5 quarters since.
Lebenthal Asset Management's Pfizer position peaked at $5.96M in Q2 2016.
2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Lebenthal Asset Management's 13F filing for Q1 2017, filed 15 May 2017.